
Diabetes Research Centers
Virtual Seminar Series
Virtual Seminar Series
To address the disruption in seminars & scientific interactions at the onset of the Covid-19 pandemic, nine NIDDK-sponsored Diabetes Research Centers (DRCs) and three Centers for Diabetes Translational Research (CDTRs) established a weekly Virtual Seminar series. Anyone can register for the seminars, which are free and open to the public (registration required).


Investigator Profile: Jing Hughes, MD, PhD
Dr. Jing Hughes is an Assistant Professor at the Washington University School of Medicine in St. Louis. She is a recipient of a NIH NIDDK Gateway Award for her project "Primary Cilia in Human Type 1 Diabetes" Dr. Hughes joins the Human Pancreas Analysis Consortium (HPAC).



Investigator Profile: Amelia Linnemann, PhD
Dr. Amelia Linnemann is an Assistant Professor at Indiana University. She is a recipient of both a NIH NIDDK Gateway Award for her project "Functional and Molecular Characterization of the Human Islet Interferon Alpha Response" and a HIRN New Investigator Award for "Real-time in vivo Analysis of Islet Redox Dynamics" . Dr. Linnemann joins the Consortium on Beta Cell Death and Survival (CBDS).


Multiomics single-cell analysis of
human pancreatic islets reveals novel
cellular states in health and type 1 diabetes
human pancreatic islets reveals novel
cellular states in health and type 1 diabetes
Recent publication highlighting the unprecedented multimodal analysis of human pancreatic islets using four complementary single-cell techniques, scRNA-seq, CyTOF, spatial proteomic IMC, and immunofluorescence staining unmasked the role of exocrine ductal cells as antigen-presenting cells in human T1D.




Cellular Senescence Network (SenNet)
Funding Opportunities
Funding Opportunities
The Cellular Senescence Network (SenNet) aims to catalyze the development of a framework for mapping cellular senescence & its associated secretory phenotype at high resolution, to provide atlases of cellular senescence in multiple tissues and under diverse conditions and across the lifespan. Applications for the following are currently open:
* Tissue Mapping Center
* Technology Development & Application
* Consortium Organization & Data Coordinating Center
Applications Due: March 22, 2021


NIH Funding Opportunities
Current NIH Funding Opportunities:
“Immune Cell Engineering For Targeted Therapy And Disease Monitoring in Type 1 Diabetes”
Due: June 23, 2021
